PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Fundamental Analysis
TSX-V:PHA - TSX Venture Exchange - CA74052G1063 - Common Stock - Currency: CAD
We assign a fundamental rating of 2 out of 10 to PHA. PHA was compared to 17 industry peers in the Health Care Providers & Services industry. PHA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, PHA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year PHA has reported negative net income.
In the past year PHA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHA reported negative net income in multiple years.
Of the past 5 years PHA 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -16.94%, PHA is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
PHA has a worse Return On Equity (-306.33%) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.94% | ||
| ROE | -306.33% | ||
| ROIC | N/A |
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHA's Gross Margin of 17.63% is on the low side compared to the rest of the industry. PHA is outperformed by 75.00% of its industry peers.
In the last couple of years the Gross Margin of PHA has declined.
The Profit Margin and Operating Margin are not available for PHA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.63% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
2. Health
2.1 Basic Checks
PHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHA has more shares outstanding
PHA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PHA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.65, we must say that PHA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.65, PHA is in line with its industry, outperforming 56.25% of the companies in the same industry.
The Debt to FCF ratio of PHA is 16.50, which is on the high side as it means it would take PHA, 16.50 years of fcf income to pay off all of its debts.
PHA has a Debt to FCF ratio (16.50) which is in line with its industry peers.
PHA has a Debt/Equity ratio of 0.84. This is a neutral value indicating PHA is somewhat dependend on debt financing.
PHA has a Debt to Equity ratio (0.84) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | 16.5 | ||
| Altman-Z | 1.65 |
ROIC/WACCN/A
WACC10.8%
2.3 Liquidity
PHA has a Current Ratio of 0.63. This is a bad value and indicates that PHA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.63, PHA is in line with its industry, outperforming 43.75% of the companies in the same industry.
A Quick Ratio of 0.63 indicates that PHA may have some problems paying its short term obligations.
PHA has a Quick ratio of 0.63. This is comparable to the rest of the industry: PHA outperforms 43.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
The earnings per share for PHA have decreased strongly by -632.19% in the last year.
PHA shows a strong growth in Revenue. In the last year, the Revenue has grown by 75.01%.
PHA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.58% yearly.
EPS 1Y (TTM)-632.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17.38%
Revenue 1Y (TTM)75.01%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%42.96%
3.2 Future
The Earnings Per Share is expected to grow by 30.18% on average over the next years. This is a very strong growth
PHA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.52% yearly.
EPS Next Y88.14%
EPS Next 2Y43.59%
EPS Next 3Y30.18%
EPS Next 5YN/A
Revenue Next Year-8.95%
Revenue Next 2Y-2.07%
Revenue Next 3Y0.52%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PHA. In the last year negative earnings were reported.
Also next year PHA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
PHA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PHA is cheaper than 81.25% of the companies in the same industry.
PHA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PHA is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.31 | ||
| EV/EBITDA | 9.64 |
4.3 Compensation for Growth
PHA's earnings are expected to grow with 30.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.59%
EPS Next 3Y30.18%
5. Dividend
5.1 Amount
No dividends for PHA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:PHA (2/20/2025, 7:00:00 PM)
0.18
+0.01 (+2.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners46.21%
Ins Owner ChangeN/A
Market Cap9.99M
Analysts84.44
Price Target0.51 (183.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19%
Min Revenue beat(2)-23.88%
Max Revenue beat(2)-14.13%
Revenue beat(4)1
Avg Revenue beat(4)-8.96%
Min Revenue beat(4)-23.88%
Max Revenue beat(4)4%
Revenue beat(8)2
Avg Revenue beat(8)-5.52%
Revenue beat(12)4
Avg Revenue beat(12)4.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)69.33%
EPS NY rev (3m)69.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | 3.31 | ||
| P/OCF | 1.69 | ||
| P/B | 2.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.64 |
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.05
FCFY30.23%
OCF(TTM)0.11
OCFY59.33%
SpS2.85
BVpS0.07
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.94% | ||
| ROE | -306.33% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.63% | ||
| FCFM | 1.91% |
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
F-Score4
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | 16.5 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 42.67% | ||
| Cap/Sales | 1.84% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 98.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 1.65 |
F-Score4
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)35.11%
Cap/Depr(5y)76.64%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-632.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17.38%
EPS Next Y88.14%
EPS Next 2Y43.59%
EPS Next 3Y30.18%
EPS Next 5YN/A
Revenue 1Y (TTM)75.01%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%42.96%
Revenue Next Year-8.95%
Revenue Next 2Y-2.07%
Revenue Next 3Y0.52%
Revenue Next 5YN/A
EBIT growth 1Y-123.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.85%
EBIT Next 3Y12.89%
EBIT Next 5YN/A
FCF growth 1Y194.32%
FCF growth 3Y400.26%
FCF growth 5Y56.2%
OCF growth 1Y566.77%
OCF growth 3Y44.26%
OCF growth 5Y70.26%